Illumina (ILMN) drops as Roche deal apparently falls through
Posted on January 07, 2013 at 10:59 AM EST
Normal 0 false false false MicrosoftInternetExplorer4 Illumina Inc. (NASDAQ: ILMN) fell back by 8.3% to $50.22 on Monday after Roche Holding AG Chairman Franz Humer said in an interview that the company does not plan to buy the gene sequencing specialist. Share volume was 3.7 million, more than doubling its daily average /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;}